CIPLA
Cipla
Pharma · quarter ended 2024-12-31
- Revenue
- ₹7,073 Cr
- Expenses
- ₹5,378 Cr
- Operating profit
- ₹1,694 Cr
- Op. margin
- 24.0%
- Net profit
- ₹1,575 Cr
Where the revenue comes from
| Segment | Revenue | Share | Segment result | Segment margin |
|---|---|---|---|---|
| Pharmaceuticals | ₹6,778 Cr | 95.2% | ₹1,889 Cr | 27.9% |
| New ventures | ₹341 Cr | 4.8% | ₹42 Cr | 12.3% |